Why So Many on BP Meds Still Miss Target - Top_Thought_Leaders - MDSpire

Why So Many on BP Meds Still Miss Target

Most U.S. adults with hypertension missed blood pressure targets—including those on treatment—highlighting gaps in initiation and intensification of therapy, new JAMA data show.

  • By

  • Kathryn Wighton

  • February 2, 2026

  • 3 min

Share

Top Thought Leaders in Pathology

Brief introduction explaining scope and methodology.

Original Source(s)

Why So Many on BP Meds Still Miss Target

  • by Kathryn Wighton

  • February 2, 2026

Related Content

Systemic immune-inflammation index predicts post-thrombectomy outcomes and reveals a mediating role in the association between neurocardiac stress and prognosis: a multicenter study

Machine Learning Prediction Model for Dyslipidemia and Its Association With Atherothrombotic Events in 3 Independent Cohorts From South Korea, Japan, and the United Kingdom: Algorithm Development and Validation Study

Pheochromocytoma complicated with acute myocardial infarction and cerebral infarction: a case report